---
figid: PMC1906805__ar2141-1
figlink: /pmc/articles/PMC1906805/figure/F1/
number: F1
caption: Osteoclast differentiation. Cells of the mylomonocytic lineage (appropriate
  sources for in vitro differentiation are cells from bone marrow, monocytes, spleen
  or RAW 264.7 cells) under the influence of macrophage-colony stimulating factor
  (M-CSF) and receptor activator of NFκB ligand (RANKL) differentiate into osteoclasts.
  Depicted above this differentiation pathway is the potential role for T lymphocytes
  in enhancing or fulfilling this process. Upon activation of osteoclasts following
  engagement of the T cell receptor (TCR), T lymphocytes may produce several factors
  that promote osteoclast formation (RANKL and IL-7) or the production of RANKL by
  fibroblast and stromal cells (for example, IL-1, IL-6, IL-17). Below the differentiation
  pathway, the inhibitory actions of T lymphocytes are presented. T lymphocytes produce
  a vast array of inhibitory molecules, and several of these are elevated in response
  to IL-4, IL-12, IL-15, IL-18, IL-23 and osteoprotegerin (OPG). GM-CSF, granulocyte
  macrophage-colony stimulating factor; sFRP, secreted Frizzled-related protein; OCIL,
  osteoclast inhibitory lectin.
pmcid: PMC1906805
papertitle: Impact of cytokines and T lymphocytes upon osteoclast differentiation
  and function.
reftext: Matthew T Gillespie. Arthritis Res Ther. 2007;9(2):103-103.
pmc_ranked_result_index: '139681'
pathway_score: 0.9208298
filename: ar2141-1.jpg
figtitle: Osteoclast differentiation
year: '2007'
organisms: Homo sapiens
ndex: 539e1d2b-defb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC1906805__ar2141-1.html
  '@type': Dataset
  description: Osteoclast differentiation. Cells of the mylomonocytic lineage (appropriate
    sources for in vitro differentiation are cells from bone marrow, monocytes, spleen
    or RAW 264.7 cells) under the influence of macrophage-colony stimulating factor
    (M-CSF) and receptor activator of NFκB ligand (RANKL) differentiate into osteoclasts.
    Depicted above this differentiation pathway is the potential role for T lymphocytes
    in enhancing or fulfilling this process. Upon activation of osteoclasts following
    engagement of the T cell receptor (TCR), T lymphocytes may produce several factors
    that promote osteoclast formation (RANKL and IL-7) or the production of RANKL
    by fibroblast and stromal cells (for example, IL-1, IL-6, IL-17). Below the differentiation
    pathway, the inhibitory actions of T lymphocytes are presented. T lymphocytes
    produce a vast array of inhibitory molecules, and several of these are elevated
    in response to IL-4, IL-12, IL-15, IL-18, IL-23 and osteoprotegerin (OPG). GM-CSF,
    granulocyte macrophage-colony stimulating factor; sFRP, secreted Frizzled-related
    protein; OCIL, osteoclast inhibitory lectin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRB
  - IL17A
  - CD69
  - TRD
  - TNFSF11
  - IL13
  - IL18
  - IL1A
  - TRA
  - IL10
  - TNFRSF11B
  - CLEC2D
  - IL12B
  - CSF2
  - CSF1
  - TRG
  - IL23A
  - IL1B
  - IL7
  - IL12A
  - IL4
  - IL3
  - IL6
  - IFNB1
genes:
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: IL-17
  symbol: IL-17
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: CD69,
  symbol: CD69
  source: hgnc_symbol
  hgnc_symbol: CD69
  entrez: '969'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: RANKL
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
- word: IL-13
  symbol: IL-13
  source: hgnc_alias_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-1,
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: IL-10,
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: OPG
  symbol: OPG
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF11B
  entrez: '4982'
- word: OCIL,
  symbol: OCIL
  source: hgnc_alias_symbol
  hgnc_symbol: CLEC2D
  entrez: '29121'
- word: IL-4,IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: GM-CSF,
  symbol: GM-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF2
  entrez: '1437'
- word: M-CSF
  symbol: M-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF1
  entrez: '1435'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: IL-23
  symbol: IL-23
  source: hgnc_alias_symbol
  hgnc_symbol: IL23A
  entrez: '51561'
- word: IL-1,
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-7
  symbol: IL-7
  source: hgnc_alias_symbol
  hgnc_symbol: IL7
  entrez: '3574'
- word: IL-4,IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-4,
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL-3
  symbol: IL-3
  source: hgnc_alias_symbol
  hgnc_symbol: IL3
  entrez: '3562'
- word: IL-1,IL-6,IL-17
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IFN-B
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
chemicals: []
diseases: []
figid_alias: PMC1906805__F1
redirect_from: /figures/PMC1906805__F1
figtype: Figure
---
